Cellphire Therapeutics, Inc. Employee Directory
Biotechnology ResearchMaryland, United States11-50 Employees
Cellphire Therapeutics, Inc. is a clinical-stage biotechnology company based in Rockville, Maryland, focused on developing next-generation therapeutics through its cell stabilization technology, applicable across various cell types including platelets. Its lead product, Thrombosomes, is a freeze-dried hemostatic agent derived from human platelets and is being evaluated in a Phase I clinical trial. The company envisions broad potential applications ranging from trauma and wound care to imaging, targeted drug delivery, and regenerative medicine. Its products are intended for use in healthcare settings that require stabilized cellular therapies, including scenarios where liquid-stored platelets are unavailable or in short supply. In addition to Thrombosomes, the company is pursuing development programs such as CLPH-511, an injectable suspension of frozen activated platelets, to address platelet shortages. As a biotechnology firm focused on allogeneic cellular therapeutics, Cellphire sits within the broader fields of regenerative medicine and cellular therapies.
1-888-653-2347 
support@leadiq.com 
